ICON Stock Forecast
NASDAQ: ICLRHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
Market open · Delayed 15 min · as of Oct 9, 10:50 AM ET
ICLR analyst consensus
Consensus (18 analysts)
buy
Avg. price target
$184.41+11.45%
- Strong buy 1
- Buy 9
- Hold 7
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 18 Wall Street analysts covering ICON (2026-10-09), 10 rate the stock a buy or strong buy, 7 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $184.41, with a high estimate of $210.00 and a low estimate of $155.00. The average target implies upside of 11.4% from the current price of $165.47.
The spread between the highest and lowest targets is 35.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ICLR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 6% |
| Buy | 9 | 50% |
| Hold | 7 | 39% |
| Sell | 0 | 0% |
| Strong sell | 1 | 6% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $155.00 | -6.33% |
| Average target | $184.41 | +11.45% |
| High target | $210.00 | +26.91% |